These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2671737)
1. Surfactant for respiratory distress syndrome. Bierman SF N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737 [No Abstract] [Full Text] [Related]
2. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042 [No Abstract] [Full Text] [Related]
3. Synthetic surfactant. Long W Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442 [TBL] [Abstract][Full Text] [Related]
4. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Chima RS; Zingarelli B Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382 [No Abstract] [Full Text] [Related]
5. Surfactant and the neonatal lung. Gibson AT Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038 [TBL] [Abstract][Full Text] [Related]
7. Synthetic surfactants in infants with respiratory distress syndrome. Perlman JM; Moya F N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992 [No Abstract] [Full Text] [Related]
8. RDS and surfactant replacement: the double-edged sword. Etherington H; Lawrence J; Davis D Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163 [No Abstract] [Full Text] [Related]
12. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome]. Fujiwara T; Chida S; Konishi M Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254 [TBL] [Abstract][Full Text] [Related]
13. Fifth time's the charm for infant respiratory distress drug. Katsnelson A Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949 [No Abstract] [Full Text] [Related]
14. Urine output in infants with respiratory distress syndrome treated with surfactant. Hamdan AH; Shaw NJ Clin Pediatr (Phila); 2000 Jul; 39(7):421-5. PubMed ID: 10914308 [No Abstract] [Full Text] [Related]
15. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies. Coulter DM; Jung AL J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423 [TBL] [Abstract][Full Text] [Related]
16. New avenues in surfactant research. Robertson B Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993 [No Abstract] [Full Text] [Related]
17. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease? Clark HW Neonatology; 2010 Jun; 97(4):380-7. PubMed ID: 20551708 [TBL] [Abstract][Full Text] [Related]
18. Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials. Leviton A; VanMarter L; Kuban KC Pediatrics; 1989 Nov; 84(5):915-22. PubMed ID: 2677963 [No Abstract] [Full Text] [Related]
19. [On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents]. Jarre W; Ketterle W; Reinwein H Helv Paediatr Acta; 1965 Apr; 20(1):27-39. PubMed ID: 5828973 [No Abstract] [Full Text] [Related]
20. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]